greeksoup/ stock research

AdaptHealth (AHCO) FY2022 results: revenue $3.0 billion, up 21.0% on the year

AdaptHealth Corp. (AHCO) reported revenue of $3.0 billion for fiscal 2022, the year ended 31 December 2022, up 21.0% on the year before. Net income was $69 million, down 55.6%, and diluted earnings per share $0.33. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2023.

Revenue
$3.0 billion
+21.0% on the year
FY2018FY2022
Operating margin
6.4%
9.2% a year earlier
FY2018FY2022
Net income
$69 million
-55.6% on the year
FY2018FY2022
Diluted EPS
$0.33
-50.7% on the year
FY2018FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue2,9712,4551,056+21.0%
Cost of revenue2,3902,009899+19.0%
Gross profit580446158+30.2%
Gross margin19.5%18.2%14.9%
Operating income19022671.3-15.6%
Operating margin6.4%9.2%6.8%
Interest expense10995.241.4+14.9%
Pre-tax income97.9191-206-48.7%
Income tax24.832.8-12.0-24.5%
Effective tax rate25.3%17.2%n/a
Net income69.3156-162-55.6%
Net margin2.3%6.4%-15.3%
Diluted EPS$0.33$0.67-$3.08-50.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow374276196+35.6%
Capital expenditure39120339.8+92.5%
Free cash flow-17.672.4156
Free cash flow margin-0.6%2.9%14.8%
Cash from investing-411-1,825-816
Cash from financing-66.11,599643
Depreciation and amortisation35125882.4+36.1%
Share-based compensation22.425.318.7-11.6%
Buybacks14.00.00.0
Diluted shares, weighted139m133m52m+4.5%
Shares outstanding at period end134m134mn/a+0.4%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity2,1512,062355+4.3%
Non-controlling interest6.64.8-74.0+38.0%
Debt2,1882,204785-0.7%
Operating lease liabilities104120n/a-13.1%
Finance lease liabilities4.00.1n/a+2,892.4%
Other liabilities765860748-11.0%
Total liabilities and equity5,2205,2501,813-0.6%
Fixed assetsn/a399110
Goodwill3,5453,513999+0.9%
Intangible assets163202116-19.5%
Cash and equivalents46.3150100.0-69.1%
Receivables359360171-0.2%
Inventory12812358.8+3.8%
Other assets978504258+93.9%
Total assets5,2205,2501,813-0.6%

10-K for the year ended 31 December 2022, filed 28 February 2023: the filing.